HIGHLIGHTS
- who: Report and collaborators from the Medicine, North Central Regional Health Authority, Port of Spain, TTO Internal Medicine, University of Kansas have published the research work: Review began 01/03/2023 Review ended 01/25/2023 Published 01/26/2023 u00a9 Copyright, in the Journal: (JOURNAL) of January/26,/2023
- what: We presented the case of a 15-year-old South Asian male who developed suspected POTS two weeks after receiving the Pfizer-BioNTech COVID-19 vaccine booster, which was successfully managed with low-dose fludrocortisone and ivabradine.
SUMMARY
The coronavirus . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.